High levels of CXCR4 expression (> 90%) on CK+PBMCs were also observed by other authors in small pilot studies involving patients with non-small cell lung cancer [26] or patients with metastatic renal cancer [27]. The gene discussed is CXCR4; the disease is non-small cell lung carcinoma.